The Ghana Primary Tube Versus Trabeculectomy Study
Launched by TEMA CHRISTIAN EYE CENTER · Mar 14, 2014
Trial Information
Current as of October 21, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 to 85 years, inclusive
- • Open angle glaucoma. Including primary open angle glaucoma, pseudoexfoliative and pigmentary glaucoma
- • Intraocular pressure 18 - 40 mmHg on maximal tolerated or maximal affordable medical therapy
- • Informed consent given and consent form signed.
- Exclusion Criteria:
- • Unwilling or unable to give consent, unwilling to accept randomisation, or unable to return for scheduled protocol visits
- • Pregnant or nursing women
- • No light perception vision
- • Previous incisional intraocular surgery, other than uncomplicated clear corneal cataract surgery
- • Previous ocular laser in study eye
- • Iris neovascularisation or proliferative retinopathy
- • Primary angle closure or primary angle closure glaucoma
- • Iridocorneal endothelial syndrome or anterior segment dysgenesis
- • Epithelial or fibrous downgrowth
- • Aphakia
- • Chronic or recurrent uveitis
- • Steroid-induced glaucoma
- • Severe posterior blepharitis
- • Unwilling to discontinue contact lens use after surgery
- • Previous cyclodestructive procedure
- • Glaucoma secondary to penetrating keratoplasty, trauma, retinal disease/surgery or neovascular disease
- • Conjunctival scarring from prior ocular surgery, trauma or cicatrizing disease precluding a superior trabeculectomy
- • Need for glaucoma surgery combined with other ocular procedures (i.e. cataract surgery, penetrating keratoplasty, or retinal surgery) or anticipated need for urgent additional ocular surgery
About Tema Christian Eye Center
Tema Christian Eye Center is a leading healthcare institution dedicated to advancing ophthalmic care through innovative research and clinical trials. With a commitment to enhancing vision health in the community, the center focuses on the development and evaluation of cutting-edge therapies and interventions for various eye conditions. By collaborating with expert researchers and healthcare professionals, Tema Christian Eye Center aims to contribute to the global understanding of eye diseases and improve patient outcomes through evidence-based practices. Their rigorous approach to clinical trials ensures the highest standards of safety and efficacy in the pursuit of better vision for all.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tema, Ghana
Patients applied
Trial Officials
Alexander Spratt, MBBCh FRCOphth
Principal Investigator
Tema Christian Eye Center
Keith Barton, MBBCh MD FRCP FRCOphth
Study Chair
Moorfields Eye Hospital NHS Foundation Trust
Donald L Budenz, MD MPH
Study Chair
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials